Amedisys, Inc.
AMEDNASDAQHealthcare
$100.99
+$0.01(+0.01%)
Market Cap$3.3B
P/E Ratio—
52W High$101.02
52W Low$82.15
Amedisys, Inc. (AMED) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AMED · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.35B | $2.24B | $2.22B | $2.21B | $2.07B |
| Cost of Revenue | $1.33B | $1.25B | $1.26B | $1.23B | $1.19B |
| Gross Profit | $1.02B | $0.99B | $0.96B | $0.98B | $0.89B |
| Gross Margin %(computed) | 43.34% | 44.31% | 43.31% | 44.30% | 42.78% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.79B | $0.26B | $0.75B | $0.71B | $0.67B |
| Total Operating Expenses | $0.92B | $0.83B | $0.78B | $0.73B | $0.66B |
| Operating Income | $0.09B | $0.16B | $0.18B | $0.25B | $0.22B |
| Operating Margin %(computed) | 4.03% | 6.99% | 8.13% | 11.38% | 10.58% |
| Interest Income | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.03B | $0.03B | $0.02B | $0.01B | $0.01B |
| Income Before Tax | $0.09B | $0.04B | $0.16B | $0.28B | $0.21B |
| Income Tax Expense | $0.05B | $0.05B | $0.04B | $0.07B | $0.03B |
| Net Income | $0.04B | ($0.01B) | $0.12B | $0.21B | $0.18B |
| Net Margin %(computed) | 1.84% | -0.44% | 5.34% | 9.44% | 8.86% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.32 | $-0.30 | $3.65 | $6.41 | $5.64 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| EBITDA | $0.07B | $0.22B | $0.21B | $0.32B | $0.25B |
| EBITDA Margin %(computed) | 3.13% | 9.70% | 9.33% | 14.48% | 12.10% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Amedisys, Inc. data
About Amedisys, Inc. (AMED) Income Statement
Amedisys, Inc. (AMED) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, AMED reported revenue of $2.35B, gross profit of $1.02B (gross margin 43.34%), and net income of $0.04B — a net profit margin of 1.84%.
Frequently asked questions
AMED · 4 questionsAmedisys, Inc. (AMED) reported revenue of $2.35B for 2024, up 5.0% year-over-year.
AMED revenueAMED salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08